We would like to share with you our personal view, beliefs and approach about the research that is presented on these pages.
We both value the research of modern science and the many developments that have been discovered.
We also value the depth of wisdom and knowledge of traditional and classical five element acupuncture, which integrates the many aspects of body and mind.
We acknowledge the information gained from research, and we endevaour to use it where appropriate when meeting the needs of an individual who is suffering in health.
We hope later to share more information on the five elements of acupuncture.
This site was last updated on
18th March 2020
Copyright O 2020 Allrights reserved
Every effort has been made to ensure that the information provided in this site is accurate. It is not the intention to mislead or misinform anyone.
(2017) Acupuncture for the treatment of gastro-
'Results A total of 12 trials involving 1235 patients were included. Meta-
Conclusion This meta-
Zhu J, Guo Y, Liu S, et al (2017) Acupuncture for the treatment of gastro-
(2016) Individualized Acupuncture for Symptom Relief in Functional Dyspepsia: A Randomized Controlled Trial
‘Objectives: This study was implemented to evaluate the effect of individualized acupuncture treatment (AT) on functional dyspepsia (FD).
Methods: A randomized, waitlist-
Results: After the first 4 weeks, the proportion of responders significantly improved (59% in AT group [n = 37] versus 3% in control group [n = 39]; p < 0.001). The difference was no longer significant at 8 weeks, at which point the waitlist control group showed similar improvement after receiving AT (68% in the AT group versus 79% in the control group). Total NDI scores were significantly reduced in the AT group compared with the waitlist group (p = 0.03). Among NDI items, discomfort (p = 0.01), burning (p = 0.02), fullness after eating (p = 0.02), and burping (p = 0.02) were significantly improved in the AT group compared with the control group. No significant differences were observed between groups in other secondary variables.
Conclusion: Individualized AT adequately relieves symptoms in patients with FD, and this effect may persist up to 8 weeks.’